0001179110-20-005866.txt : 20200513 0001179110-20-005866.hdr.sgml : 20200513 20200513145023 ACCESSION NUMBER: 0001179110-20-005866 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200511 FILED AS OF DATE: 20200513 DATE AS OF CHANGE: 20200513 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Martin Gilles Gerard Jean CENTRAL INDEX KEY: 0001597047 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30833 FILM NUMBER: 20872563 MAIL ADDRESS: STREET 1: BRUKER CORPORATION STREET 2: 40 MANNING ROAD CITY: BILLERICA STATE: MA ZIP: 01821 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRUKER CORP CENTRAL INDEX KEY: 0001109354 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 043110160 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 BUSINESS PHONE: 978663-3660 MAIL ADDRESS: STREET 1: 40 MANNING RD CITY: BILLERICA STATE: MA ZIP: 01821 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER BIOSCIENCES CORP DATE OF NAME CHANGE: 20030721 FORMER COMPANY: FORMER CONFORMED NAME: BRUKER DALTONICS INC DATE OF NAME CHANGE: 20000315 4 1 edgar.xml FORM 4 - X0306 4 2020-05-11 0 0001109354 BRUKER CORP BRKR 0001597047 Martin Gilles Gerard Jean BRUKER CORPORATION 40 MANNING ROAD BILLERICA MA 01821 1 0 0 0 Common Stock 2020-05-11 4 M 0 10000 21.74 A 24657 D Common Stock 2020-05-11 4 M 0 10000 19.12 A 34657 D Common Stock 2020-05-11 4 M 0 10000 24.00 A 44657 D Common Stock 2020-05-11 4 S 0 30000 38.8317 A 14657 D Stock Option (Right to Purchase) 21.74 2020-05-11 4 M 0 10000 0 D 2017-02-10 2024-02-10 Common Stock 10000 0 D Stock Option (Right to Purchase) 19.12 2020-05-11 4 M 0 10000 0 D 2018-01-05 2025-01-05 Common Stock 10000 0 D Stock Option (Right to Purchase) 24.00 2020-05-11 4 M 0 10000 0 D 2019-01-05 2026-01-05 Common Stock 10000 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.31 to $39.25, inclusive. The reporting person undertakes to provide to Bruker Corporation, any security holder of Bruker Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/Michael Rich, Attorney-in-Fact 2020-05-13